Review Article
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models
Table 5
Effects of other agents, in a CB receptor-dependent manner, in animal models of CINP.
| CINP model | Molecule | Effects | Effects of CB receptor antagonists on the activity of the compound | Reference | Chemotherapy drug | Animal |
| Paclitaxel | Female and male BALB/c mice | Indomethacin (NSAID) plus minocycline (semisynthetic tetracycline antibiotic) | Reduced established thermal hyperalgesia | CB1 antagonist AM251 antagonised | [53] | Paclitaxel | Male Sprague-Dawley rats | Desipramine (tricyclic antidepressant) | Prevented the development of mechanical and cold allodynia | CB1 antagonist AM251 and CB2 antagonist AM630 partially antagonised | [52] |
|
|
NSAID, nonsteroidal anti-inflammatory drug.
|